AMGEN ANNOUNCES WEBCAST OF 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
Amgen (AMGN) has announced it will release its fourth quarter and full year 2024 financial results on Tuesday, February 4, 2025, after U.S. market close. The company will host a conference call with the investment community at 4:30 p.m. ET, featuring Chairman and CEO Robert A. Bradway along with other senior management team members.
The conference call will be broadcast live via webcast and will be accessible to media, investors, and the general public through Amgen's website. The webcast will remain available for replay for at least 90 days following the event.
Amgen (AMGN) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 martedì 4 febbraio 2025, dopo la chiusura del mercato statunitense. L'azienda ospiterà una conference call con la comunità degli investitori alle 16:30 ET, con la partecipazione del Presidente e CEO Robert A. Bradway insieme ad altri membri del team di alta direzione.
La conference call sarà trasmessa in diretta via webcast e sarà accessibile a media, investitori e pubblico generale attraverso il sito web di Amgen. Il webcast rimarrà disponibile per la riproduzione per almeno 90 giorni dopo l'evento.
Amgen (AMGN) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 el martes 4 de febrero de 2025, después del cierre del mercado estadounidense. La compañía llevará a cabo una conferencia telefónica con la comunidad inversora a las 4:30 p.m. ET, con la participación del Presidente y CEO Robert A. Bradway, junto con otros miembros del equipo directivo superior.
La conferencia telefónica se transmitirá en vivo a través de un webcast y estará disponible para los medios, inversores y el público en general a través del sitio web de Amgen. El webcast estará disponible para su reproducción durante al menos 90 días después del evento.
Amgen (AMGN)은 2024년 4분기 및 연간 재무 결과를 2025년 2월 4일 화요일, 미국 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 동부 표준시 기준 오후 4:30에 투자 커뮤니티와의 전화 회의를 개최할 예정이며, 이 회의에는 회장 겸 CEO인 Robert A. Bradway와 기타 고위 경영진이 참석합니다.
전화 회의는 웹캐스트를 통해 실시간으로 방송되며, Amgen의 웹사이트를 통해 미디어, 투자자 및 일반 대중이 접근할 수 있습니다. 웹캐스트는 이벤트 이후 최소 90일 동안 재생 가능하게 유지됩니다.
Amgen (AMGN) a annoncé qu'il publiera ses résultats financiers du quatrième trimestre et de l'année 2024 le mardi 4 février 2025, après la clôture des marchés américains. L'entreprise organisera une conférence téléphonique avec la communauté des investisseurs à 16h30 ET, avec la participation du Président et CEO Robert A. Bradway ainsi que d'autres membres de l'équipe de direction senior.
La conférence téléphonique sera diffusée en direct via un webinaire et sera accessible aux médias, investisseurs et au grand public sur le site web d'Amgen. Le webinaire restera disponible en replay pendant au moins 90 jours après l'événement.
Amgen (AMGN) hat angekündigt, dass es am Dienstag, den 4. Februar 2025, nach Handelsende der US-Märkte die finanziellen Ergebnisse des vierten Quartals und des gesamten Jahres 2024 veröffentlichen wird. Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz mit der Investmentgemeinschaft abhalten, an der der Vorsitzende und CEO Robert A. Bradway sowie andere Mitglieder des oberen Managementteams teilnehmen werden.
Die Telefonkonferenz wird live über einen Webcast übertragen und ist für Medienvertreter, Investoren und die breite Öffentlichkeit über die Website von Amgen zugänglich. Der Webcast wird für mindestens 90 Tage nach der Veranstaltung als Wiederholung zur Verfügung stehen.
- None.
- None.
Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube and Threads.
CONTACT: Amgen,
Elissa Snook, 609-251-1407 (media)
Justin Claeys, 805-313-9775 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2024-fourth-quarter-and-full-year-financial-results-302365715.html
SOURCE Amgen
FAQ
When will Amgen (AMGN) release its Q4 and full year 2024 earnings?
What time is Amgen's (AMGN) Q4 2024 earnings call?
Who will participate in Amgen's (AMGN) Q4 2024 earnings call?
How long will Amgen's (AMGN) Q4 2024 earnings webcast be available for replay?
